Fierce Biotech Next Gen 2022

Max Bayer is a staff writer for Fierce Biotech. He joined after more than three years at CBS News, two of which were spent covering the twists and turns of the COVID-19 pandemic, from infection trends to CDC guidelines. He graduated from the University of Wisconsin-Madison in 2018... Read More →

Dr. Andrew Adams serves VP-Neurodegeneration Research & Co-Director of Lilly Institute for Genetic Medicines. He previously served as Vice President for Lilly Genetic Medicine. In this role, Andrew is responsible for leading the discovery of new types of therapies, such as genetic... Read More →